34 results

• General Causation Between Abilify and Compulsive Behavior to be Addressed by end of Summer

  February 8, 2017

  Austin Kirk

  The judge presiding over all Abilify lawsuits hopes to settle issues of general causation about the link between Abilify and compulsive gambling by the end of this summer, paving the way for bellwether trials to begin by the end of the year.

• AstraZeneca Buys Bristol-Myers Squibb Diabetes Interests, Byetta

  February 11, 2014

  Irvin Jackson

  AstraZeneca has agreed to buy all of Bristol-Myers Squibb's diabetes drug interests, as a growing number of Byetta, Bydureon and Ongylza lawsuits continue to be filed by former users of the incretin mimetics diagnosed with cancer.

• Plavix Cases for More than 400 Plaintiffs Transferred to MDL Since July

  September 30, 2013

  Irvin Jackson

  More than 400 additional claims have been filed over Plavix safety and efficacy problems over the summer.

• Pravachol, Other Cholesterol Drugs May Cause Memory Problems: Study

  September 30, 2013

  Irvin Jackson

  A new study suggests some cholesterol drugs could impair memory with regular use.

• Plavix Hemophilia Warning Issued in UK

  September 18, 2013

  Irvin Jackson

  A number of Plavix users have developed a dangerous bleeding disorder, according to a warning letter sent out by the manufacturer.

• Plavix Stent Warning Should Be Placed in Black Box: Public Citizen

  August 22, 2013

  Irvin Jackson

  Public Citizen is calling on the FDA to add a black box warning to Plavix about the risk of major bleeding events when used with drug-eluting stents.

• Onglyza Fails Clinical Trials For Heart Attack, Stroke Prevention

  June 20, 2013

  Irvin Jackson

  The diabetes drug Onglyza proved to be no more effective than a placebo at preventing heart attacks and strokes in diabetics, according to data from a recent clinical trial.

• Drug Makers to Present New Byetta Data At Diabetes Conference

  June 19, 2013

  Irvin Jackson

  AstraZeneca and Bristol-Myers Squibb will unveil new studies on diabetes drugs at an upcoming conference.

• Plavix Lawsuits Filed By More than 1,000 Plaintiffs Removed to MDL

  June 11, 2013

  Austin Kirk

  A conference in the Plavix litigation has been reset for next month, as complaints involving 1,000 plaintiffs were transferred into the MDL this week.

• Organizational Conference in Plavix MDL to be Held Next Week

  June 4, 2013

  Austin Kirk

  Following the centralization of all federal Plavix lawsuits earlier this year as part of an MDL or Multidistrict Litigation, an...